Brian Hangil Kim MD
Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
350 Engle Street1st Floor Berrie BuildingEnglewood, NJ 07631
Phone+1 201-568-5250
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Kim is a hematologist based in Englewood, NJ, with a focus on clotting disorders, bleeding disorders, hematologic malignancies, and myeloproliferative disorders. He is also the medical oncology director of the division of Urologic Oncology at Englewood Health, with a focus on cancers of the prostate, bladder, kidneys, and testicles. He completed his residency in internal medicine at Kaiser Permanente Southern California and his fellowship in hematology and medical oncology at Zucker School of Medicine at Hofstra/Northwell. Dr. Kim has published research on various topics, with his work being frequently cited by peers in the field.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2005 - 2008
Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 2001 - 2004
SUNY Upstate Medical UniversityClass of 2001
Certifications & Licensure
CA State Medical License 2002 - Present
NJ State Medical License 2008 - 2027
NY State Medical License 2005 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 23 citationsMechanisms of Tertiary Neurodegeneration after Neonatal Hypoxic-Ischemic Brain Damage.Steven W Levison, Eridan Rocha-Ferreira, Brian H Kim, Henrik Hagberg, Bobbi Fleiss
Pediatric Medicine. 2022-08-28 - 58 citationsHypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.Brian H. Kim, Thomas Bradley, Julia Tai, Daniel R. Budman
Oncology. 2009-02-25
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
